Diaceutics PLC

Diaceutics PLC is a global leader in the precision medicine diagnostics space, providing end-to-end solutions for the launch of precision medicine diagnostics. Their platform, DXRX - The Diagnostic Network®, is the world's first diagnostic commercialisation platform for precision medicine. It integrates multiple pipelines of real-world diagnostic testing data from a global network of laboratories, enabling a vibrant marketplace where all stakeholders in Precision Medicine come to find trusted partners for collaboration. Diaceutics' unique ability to amalgamate its multiple clinical testing data sources and provide clear actionable analysis to pharmaceutical companies is a key value driver for their DXRX platform.

Diaceutics is dedicated to ensuring that every patient has access to the right treatment at the right time. Their mission is to close the gaps in biomarker testing, and they achieve this through a combination of data-driven insights, a global network of laboratories, and a suite of tech-enabled services. Their research has identified 7 “gaps” in which patients are being lost in their testing journey, and they are actively working to close these gaps through education, collaboration, and innovative solutions.

Diaceutics is a global company dedicated to improving patient outcomes by ensuring every patient has access to the right treatment at the right time. They provide leading pharmaceutical companies with end-to-end solutions for the launch of precision medicine diagnostics through their DXRX platform. This platform integrates real-world diagnostic testing data from a global network of labs, enabling data-driven insights, strategic partnerships, and innovative services to bridge gaps in testing and ultimately accelerate the adoption of personalized medicine.

Diaceutics promotes a collaborative and innovative culture focused on achieving positive outcomes for patients by bridging the gap between healthcare stakeholders. They value teamwork, global expertise, and a strong commitment to improving the precision medicine landscape. Their open business model encourages partnerships and collaboration, creating a dynamic and forward-thinking environment where employees can contribute to a meaningful mission.

Diaceutics' website does not mention a specific approach to diversity, equity, and inclusion. NONE